Sclerostin regulation, microarchitecture, and advanced glycation end-products in the bone of elderly women with type 2 diabetes
Increased circulating sclerostin and accumulation of advanced glycation end‐products (AGEs) are two potential mechanisms underlying low bone turnover and increased fracture risk in type 2 diabetes (T2D). Whether the expression of the sclerostin‐encoding SOST gene is altered in T2D, and whether it is...
Main Authors: | Piccoli, A, Cannata, F, Strollo, R, Pedone, C, Leanza, G, Russo, F, Greto, V, Isgrò, C, Quattrocchi, CC, Massaroni, C, Silvestri, S, Vadalà, G, Bisogno, T, Denaro, V, Pozzilli, P, Tang, SJ, Silva, MJ, Conte, C, Papalia, R, Maccarrone, M, Napoli, N |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Wiley
2020
|
Similar Items
-
WNT pathway and bone fragility in postmenopausal women with type 2 diabetes
by: Piccoli, A, et al.
Published: (2019) -
Oxidative Stress in Postmenopausal Women with or without Obesity
by: Giulia Leanza, et al.
Published: (2023-04-01) -
Bone canonical Wnt signaling is downregulated in type 2 diabetes and associates with higher advanced glycation end-products (AGEs) content and reduced bone strength
by: Giulia Leanza, et al.
Published: (2024-04-01) -
Serum sclerostin and bone turnover in latent autoimmune diabetes in adults
by: Napoli, N, et al.
Published: (2018) -
Beneficial Effects of Physical Activity in Diabetic Patients
by: Francesca Cannata, et al.
Published: (2020-09-01)